Improved detection and quantification of mouse cytomegalovirus by real-time PCR

Virus Research

Volumn 98, Issue 1, 2003, Pages 17-25

  Vliegen, Inge ^a   Herngreen, Selma ^a   Grauls, Gert ^a   Bruggeman, Cathrien ^a   Stassen, Frank ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BALB c; C57Bl 6J; Mouse cytomegalovirus; Plaque assay; Real time PCR

Indexed keywords

ACCURACY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD; BONE MARROW CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DATA ANALYSIS; GENE FREQUENCY; HEART; INTERMETHOD COMPARISON; LIVER; LUNG; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SALIVARY GLAND; SPLEEN; STRAIN DIFFERENCE; TECHNIQUE; UNINDEXED SEQUENCE; VIRUS CULTURE; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION; VIRUS TITRATION;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; MAIZE CHLOROTIC MOTTLE VIRUS;

EID: 0242721795     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2003.08.009     Document Type: Article

References (46)

1. Allan J.E., Shellam G.R. Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice. Arch. Virol. 81:1984;139-150.
2. Andrews D.M., Farrell H.E., Densley E.H., Scalzo A.A., Shellam G.R., Degli-Esposti M.A. NK1.1+ cells and murine cytomegalovirus infection: what happens in situ? J. Immunol. 166:2001;1796-1802.
3. Balthesen M., Messerle M., Reddehase M.J. Lungs are a major organ site of cytomegalovirus latency and recurrence. J. Virol. 67:1993;5360-5366.
4. Balthesen M., Dreher L., Lucin P., Reddehase M.J. The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection. J. Gen. Virol. 75:1994;2329-2336.
5. Blok, M.J., Savelkouls, K.G.M., Grauls, G.E.L.M., Bruggerman, C.A., Vink, C., 2001. Immediately early-1 mRNA expression and virus production are restricted during the acute phase of rat cytomegalovirus infection in immunocompetent rats. In: Blok, M.J. (Ed.), Monitoring the course of CMV infection by detection of specific viral transcripts. Thesis University Maastricht, pp. 91-124 (ISBN 90-9015374-9015378).
6. Boom R., Sol C.J., Salimans M.M., Jansen C.L., Wertheim-van Dillen P.M., van der Noordaa J. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:1990;495-503.
7. Britt, W.J., Alford, C.A., 1996. Cytomegalovirus. In: Fields, B.N., Knipe, D.M., Howley, P.M. (Eds.), Fields Virology, third ed. Lippincott-Raven Publishers, Philadelphia, pp. 2493-2523.
8. Bruggeman C.A., Meijer H., Dormans P.H., Debie W.M., Grauls G.E., van Boven C.P. Isolation of a cytomegalovirus-like agent from wild rats. Arch. Virol. 73:1982;231-241.
9. Bustin S.A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25:2000;169-193.
10. Chalmer J.E., Mackenzie J.S., Stanley N.F. Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J. Gen. Virol. 37:1977;107-114.
11. Collins T., Pomeroy C., Jordan M.C. Detection of latent cytomegalovirus DNA in diverse organs of mice. J. Infect. Dis. 168:1993;725-729.
12. Dilloo D., Josting A., Burdach S. CMV infection modulates interleukin-6 production in human bone marrow stroma cells. Bone Marrow Transplant. 7:1991;152.
13. Field A.K., Fong J. Mouse salivary gland virus plaque assay on a stable line of mouse embryo cells. J. Bacteriol. 87:1964;1238-1239.
14. Gerard C.J., Olsson K., Ramanathan R., Reading C., Hanania E.G. Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards. Cancer Res. 58:1998;3957-3964.
15. Gibson U.E., Heid C.A., Williams P.M. A novel method for real time quantitative RT-PCR. Genome Res. 6:1996;995-1001.
16. Grundy J.E., Mackenzie J.S., Stanley N.F. Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect. Immun. 32:1981;277-286.
17. Grzimek N.K., Dreis D., Schmalz S., Reddehase M.J. Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs. J. Virol. 75:2001;2692-2705.
18. Hahn G., Jores R., Mocarski E.S. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. U.S.A. 95:1998;3937-3942.
19. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 6:1996;986-994.
20. Higuchi R., Dollinger G., Walsh P.S., Griffith R. Simultaneous amplification and detection of specific DNA sequences. Biotechnology (NY). 10:1992;413-417.
21. Higuchi R., Fockler C., Dollinger G., Watson R. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology (NY). 11:1993;1026-1030.
22. Ibanez C.E., Schrier R., Ghazal P., Wiley C., Nelson J.A. Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 65:1991;6581-6588.
23. Kercher L., Mitchell B.M. Persisting murine cytomegalovirus can reactivate and has unique transcriptional activity in ocular tissue. J. Virol. 76:2002;9165-9175.
24. Klotman M.E., Henry S.C., Greene R.C., Brazy P.C., Klotman P.E., Hamilton J.D. Detection of mouse cytomegalovirus nucleic acid in latently infected mice by in vitro enzymatic amplification. J. Infect. Dis. 161:1990;220-225.
25. Koffron A.J., Hummel M., Patterson B.K., Yan S., Kaufman D.B., Fryer J.P., Stuart F.P., Abecassis M.I. Cellular localization of latent murine cytomegalovirus. J. Virol. 72:1998;95-103.
26. Kurz S., Steffens H.P., Mayer A., Harris J.R., Reddehase M.J. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J. Virol. 71:1997;2980-2987.
27. Manning W.C., Stoddart C.A., Lagenaur L.A., Abenes G.B., Mocarski E.S. Cytomegalovirus determinant of replication in salivary glands. J. Virol. 66:1992;3794-3802.
28. Matsuzawa H., Shimizu K., Okada K., Ando K., Hashimoto K., Koga Y. Analysis of target organs for the latency of murine cytomegalovirus DNA using specific pathogen free and germfree mice. Arch. Virol. 140:1995;853-864.
29. Meyers J.D., Flournoy N., Thomas E.D. Risk factors for cytomegalovirus infection after human marrow transplantation. J. Infect. Dis. 153:1986;478-488.
30. Polic B., Jonjic S., Pavic I., Crnkovic I., Zorica I., Hengel H., Lucin P., Koszinowski U.H. Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo. J. Gen. Virol. 77:1996;217-225.
31. Pomeroy C., Delong D., Clabots C., Riciputi P., Filice G.A. Role of interferon-gamma in murine cytomegalovirus infection. J. Lab. Clin. Med. 132:1998;124-133.
32. Reddehase M.J., Balthesen M., Rapp M., Jonjic S., Pavic I., Koszinowski U.H. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J. Exp. Med. 179:1994;185-193.
33. Rice G.P., Schrier R.D., Oldstone M.B. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc. Natl. Acad. Sci. U.S.A. 81:1984;6134-6138.
34. Riera L., Gariglio M., Valente G., Mullbacher A., Museteanu C., Landolfo S., Simon M.M. Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection. Eur. J. Immunol. 30:2000;1350-1355.
35. Roizman, B., 1996. Herpes simplex viruses and their replication. In: Fields, B.N., Knipe, D.M., Howley, P.M. (Eds.), Fields Virology, third ed. Lippincott-Raven Publishers, Philadelphia, pp. 2231-2295.
36. Salazar-Mather T.P., Hamilton T.A., Biron C.A. A chemokine-to-cytokine- to-chemokine cascade critical in antiviral defense. J. Clin. Invest. 105:2000;985-993.
37. Salazar-Mather T.P., Lewis C.A., Biron C.A. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver. J. Clin. Invest. 110:2002;321-330.
38. Salem M.L., Hossain M.S. In vivo acute depletion of CD8(+) T cells before murine cytomegalovirus infection upregulated innate antiviral activity of natural killer cells. Int. J. Immunopharmacol. 22:2000;707-718.
39. Scalzo A.A., Fitzgerald N.A., Simmons A., La Vista A.B., Shellam G.R. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med. 171:1990;1469-1483.
40. Scalzo A.A., Fitzgerald N.A., Wallace C.R., Gibbons A.E., Smart Y.C., Burton R.C., Shellam G.R. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J. Immunol. 149:1992;581-589.
41. Taylor-Wiedeman J., Sissons J.G., Borysiewicz L.K., Sinclair J.H. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72:1991;2059-2064.
42. Vink C., Beuken E., Bruggeman C.A. Complete DNA sequence of the rat cytomegalovirus genome. J. Virol. 74:2000;7656-7665.
43. Wentworth B.B., French L. Plaque assay of cytomegalovirus strains of human origin. Proc. Soc. Exp. Biol. Med. 135:1970;253-258.
44. White K.L., Slobedman B., Mocarski E.S. Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection. J. Virol. 74:2000;9333-9337.
45. Yu Y., Henry S.C., Xu F., Hamilton J.D. Expression of a murine cytomegalovirus early-late protein in "latently" infected mice. J. Infect. Dis. 172:1995;371-379.
46. Yuhasz S.A., Dissette V.B., Cook M.L., Stevens J.G. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice. Virology. 202:1994;272-280.